Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial of a non-myeloablative preparative regimen using total lymphoid irradiation and anti-thymocyte globulin for older patients with relapsed lymphoid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Lymphoid Malignancies

Drugs mentioned

• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: Nantes University Hospital | Conditions: Haemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is Warranted | Phase 2 | Status: COMPLETED